Department of Surgery, Queen Mary Hospital, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Hepatol Int. 2009 Dec;3(4):571-81. doi: 10.1007/s12072-009-9148-8. Epub 2009 Aug 13.
To evaluate the outcome of liver transplantation for acute-on-chronic liver failure.
From November 1991 to December 2007, 517 patients underwent liver transplantation at Queen Mary Hospital, Hong Kong. Among them, 149 had acute-on-chronic liver failure as defined in the recent Asian Pacific Association for the Study of Liver Consensus Meeting. Their clinical data were reviewed and their survival outcomes were compared with those of patients who underwent liver transplantation for fulminant hepatic failure and for cirrhosis only in the same period.
The patients with acute-on-chronic liver failure included 50 patients having acute exacerbation of chronic hepatitis B and 99 cirrhotic patients with acute deterioration. Their median model for end-stage liver disease scores were 35 and 37, respectively. Preoperative infection (35%), hepatorenal syndrome (38%), and respiratory failure (28.8%) were common. One hundred and three patients received living donor liver grafts and 46 patients received deceased donor liver grafts. The hospital mortality rate was 4.7%. The 5-year survival rates were 93.2% for patients with acute exacerbation of chronic hepatitis B and 90.5% for cirrhotic patients with acute deterioration. The results were similar to those of the patients with fulminant hepatic failure (n = 37) and the patients having cirrhosis only (n = 301).
Liver transplantation for acute-on-chronic liver failure is life-saving, and the survival rates it attains are similar to those attained by transplantation for other liver conditions.
评估慢性加急性肝衰竭肝移植的疗效。
1991 年 11 月至 2007 年 12 月,香港玛丽医院共进行了 517 例肝移植手术,其中 149 例符合近期亚太肝脏研究学会共识会议中关于慢性加急性肝衰竭的定义。我们对这些患者的临床资料进行了回顾,并将其生存结局与同期因暴发性肝衰竭和单纯肝硬化而行肝移植患者的结局进行了比较。
慢性加急性肝衰竭患者中,50 例为慢性乙型肝炎急性加重,99 例为肝硬化急性恶化。他们的终末期肝病模型评分中位数分别为 35 和 37。术前感染(35%)、肝肾综合征(38%)和呼吸衰竭(28.8%)较为常见。103 例接受活体供肝移植,46 例接受尸体供肝移植。住院死亡率为 4.7%。慢性乙型肝炎急性加重患者的 5 年生存率为 93.2%,肝硬化急性恶化患者的 5 年生存率为 90.5%。这两组患者的结果与暴发性肝衰竭患者(n=37)和单纯肝硬化患者(n=301)的结果相似。
慢性加急性肝衰竭肝移植可挽救生命,其生存率与其他肝脏疾病肝移植的生存率相似。